פרוגילוטון
bayer israel ltd - estradiol valerate; estradiol valerate; norgestrel - טבליה - estradiol valerate 2 mg; norgestrel 0.5 mg; estradiol valerate 2 mg - norgestrel and estrogen - norgestrel and estrogen - two phase preparation for climacteric and cycle disturbances.
יאז פלוס
bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - טבליות מצופות פילם - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations
פרנדאז 50
bayer israel ltd - acarbose 50 mg - tablets - acarbose - treatment of niddm in patient's inadequatly controlled on diet alone or on diet and oral hypohlycaemia agents.
פרנדאז 100
bayer israel ltd - acarbose 100 mg - tablets - acarbose - treatment of niddm in patient's inadequatly controlled on diet alone or on diet and oral hypohlycaemia agents.
פרסולאט 10
bayer israel ltd - nifedipine - טבליות בשחרור מושהה - nifedipine 10 mg - nifedipine - nifedipine - treatment of hypertension.
אוסמו - אדאלט 30 מג
bayer israel ltd - nifedipine - טבליות בשחרור ממושך - nifedipine 30 mg - nifedipine - nifedipine - chronic stable angina, hypertension.
אוסמו - אדאלט 60 מג
bayer israel ltd - nifedipine - טבליות בשחרור ממושך - nifedipine 60 mg - nifedipine - nifedipine - chronic stable angina, hypertension.
אוסמו - אדאלט 20 מג
bayer israel ltd - nifedipine - טבליות בשחרור ממושך - nifedipine 20 mg - nifedipine - nifedipine - chronic stable angina, hypertension.
לויטרה 10 מ"ג טבליות מסיסות
bayer israel ltd - vardenafil as hydrochloride trihydrate 10 mg - tablets orodispersible - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.
ציפרוקסין 200
bayer israel ltd - ciprofloxacin as lactate 0.2 g / 100 ml - solution for infusion - ciprofloxacin - adults:uncomplicated and complicated infections caused by ciprofloxacin sensitive pathogens.children: for the treatment of acute pulmonary exacerbation of cystic fibrosis associated with pseudomonas aeroginosa infections in pediatric patients aged 5-17 years.